Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Johns Hopkins Genomics, |
RCV000850155 | SCV000992342 | uncertain significance | Ehlers-Danlos syndrome due to tenascin-X deficiency | 2019-04-08 | criteria provided, single submitter | clinical testing | This TNXB variant (rs764559504) is rare (<0.1%) in large population datasets (gnomAD: 2/243212 total alleles; 0.0008123%; no homozygotes). Additionally, c.10783C>T has not been reported in ClinVar nor the literature, to our knowledge. Of two bioinformatics tools queried, one predicts that the substitution would be damaging, while the second predicts that it would be benign. The proline residue at this position is evolutionarily conserved among primates and across most other species assessed. Bioinformatic analysis predicts that this missense variant would not affect normal exon 32 splicing, although this has not been confirmed experimentally to our knowledge. The clinical significance of c.10783C>T (p.Pro3595Ser) is uncertain at this time. |